December 9, 2020
Congratulations to Silvio Antoniak, Phd with NCSU collaborator James C. Bonner! Grant application titled “Role of PAR-2 in nanoparticle modulation of allergic lung disease” The NC TraCS proposal investigates the contribution of lung macrophage PAR2 on allergic airway disease caused by multi-walled carbon nanotubes (MWCNTs). We propose that common allergens like house dust mite allergens …
December 2, 2020
R35 grant awarded to Nigel Mackman, PhD (PI) from NHLBI/NIH The award is a 7 year grant with $600,000/year directs costs and a total amount of $6.46million. The title is “Tissue factor-dependent coagulation in thrombosis and immune responses”. The proposal will study the mechanisms of thrombosis in cancer and viral infections, including influenza A infection …
November 5, 2020
Congratulations to Patrick Ellsworth, MD, awarded the ASH Research Restart Award. This award is for $50,000 for the twelve-month term beginning November 2020. One of the Society’s newest programs, the ASH Research Restart Award program is designed to reduce the impact that the global COVID-19 pandemic response has had on the progression of research and …
October 20, 2020
Talin-1 is the principal platelet Rap1 effector of integrin activation PLATELETS AND THROMBOPOIESIS| September 3, 2020 Recent Blood paper publication, collaborated with Mark Ginsberg, MD at UCSD to identify a unique mechanism regulating integrin-mediated platelet adhesion at sites of vascular injury: Wofgang Bergmeier, PhD and David Paul, PhD are co-authors on this study, showing that …
October 19, 2020
The National Institutes of Health hereby awards this grant ~ Congratulations to Dr. Wolfgang Bergmeier, he is part of this PPG which is spearheaded by investigators at the University of California at San Diego and the La Jolla Institute for Immunology. Project Period: 08/05/2020 – 07/31/2025 Project Title: Cellular Mechanisms of Inflammation, Hemostasis, and Thrombosis …
September 27, 2020
The Oncologist “D-dimer enhances risk targeted thromboprophylaxis in ambulatory cancer patients” Background: Thromboprophylaxis for ambulatory cancer patients is effective, although uncertainties remain on who should be targeted. using D-dimer values from individuals enrolled to the AVERT trial, we sought to identify and validate a more efficient VTE risk threshold for thromboprophylaxis. Read Publication here
September 16, 2020
Congratulations to Nigel Mackman on receiving the ATVB Highly Cited Award! As a member of the Editorial Board who publish their high level science in ATVB, we will be recognizing the publication by Editorial Board members that were the most highly cited in the determination of the 2019 impact factor. Manuscript: Tissue Factor: An Essential …
September 2, 2020
What is myocarditis? How is it linked to COVID-19? And why is it a concern for athletes? Dr. Silvio Antoniak explains- One of the more concerning side effects of COVID-19 infection is myocarditis — a once rare condition of inflammation of the heart, leading to scar tissue build-up and a weakening of the heart. A …
September 2, 2020
Congratulations to Jean Marie Mwiza, a graduate research assistant in the Bergmeier and Wolberg Labs, for recently receiving an F31 research fellowship award from NIH’s NHLBI. Jean Marie’s fellowship provides ongoing stipend support, beginning January, 2021, for his project, titled “Determining the Platelet Signaling Pathway(s) Critical in Venous Thrombosis Pathogenesis”.
August 6, 2020
Silvio Antoniak, PhD, assistant professor in the UNC Department of Pathology and Laboratory Medicine and member of the UNC Blood Research Center and the UNC McAllister Heart Institute, was awarded a four-year, $2.2 million grant from the NIH-NHLBI to investigate the potential therapeutic approach in inhibiting PAR1 to treat chemotherapy-induced heart failure.
August 3, 2020
Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Publication Lori A. Holle, Dougald M. Monroe and Alisa S. Wolberg VWF (von Willebrand Factor) Is Not Required for Red Blood Cell Retention in Clots in Mice View publication
July 16, 2020
Congratulations- R01 awarded to Dr. Maria Aleman (PI), R01 was awarded on a $2 million (direct costs only) 5-year R01 grant; funding period (2020-2025). Scientific team includes outstanding scientists and collaborators, Co-Investigators Dr. Raj Kasthuri and Dr. Daniel Dominguez (not pictured). Institute: NIH/NIDDK (1R01DK124773-01) Title: Iron-sensitive RNA regulation during erythropoiesis PI: Maria Aleman PhD (Pharmacology); …